152 related articles for article (PubMed ID: 8818853)
1. A comparative study of the efficacy, safety and tolerability of azithromycin and cefaclor in the treatment of children with acute skin and/or soft tissue infections.
Montero L
J Antimicrob Chemother; 1996 Jun; 37 Suppl C():125-31. PubMed ID: 8818853
[TBL] [Abstract][Full Text] [Related]
2. An open study to compare azithromycin with cefaclor in the treatment of children with acute otitis media.
Rodriguez AF
J Antimicrob Chemother; 1996 Jun; 37 Suppl C():63-9. PubMed ID: 8818847
[TBL] [Abstract][Full Text] [Related]
3. An open comparative study of azithromycin versus cefaclor in the treatment of patients with upper respiratory tract infections.
O'Doherty B
J Antimicrob Chemother; 1996 Jun; 37 Suppl C():71-81. PubMed ID: 8818848
[TBL] [Abstract][Full Text] [Related]
4. Loracarbef (LY163892) versus cefaclor in the treatment of bacterial skin and skin-structure infections in an adult population.
McCarty J; Ruoff GE; Jacobson KD
Am J Med; 1992 Jun; 92(6A):80S-85S. PubMed ID: 1621751
[TBL] [Abstract][Full Text] [Related]
5. Azithromycin versus cefaclor in the treatment of pediatric patients with acute group A beta-hemolytic streptococcal tonsillopharyngitis.
Cremer J; Wallrauch C; Milatovic D; Braveny I
Eur J Clin Microbiol Infect Dis; 1998 Apr; 17(4):235-9. PubMed ID: 9707305
[TBL] [Abstract][Full Text] [Related]
6. Loracarbef vs. cefaclor in pediatric skin and skin structure infections.
Hanfling MJ; Hausinger SA; Squires J
Pediatr Infect Dis J; 1992 Aug; 11(8 Suppl):S27-30. PubMed ID: 1513609
[TBL] [Abstract][Full Text] [Related]
7. Azithromycin. A review of its use in paediatric infectious diseases.
Langtry HD; Balfour JA
Drugs; 1998 Aug; 56(2):273-97. PubMed ID: 9711451
[TBL] [Abstract][Full Text] [Related]
8. [Comparison of azithromycin, amoxicillin/clavulanic acid and cefaclor in the treatment of acute ENT infections].
García Callejo FJ; Velert Vila MM; Orts Alborch MH; Pardo Mateu L; Esparcia Navarro M
Acta Otorrinolaringol Esp; 1998 May; 49(4):306-12. PubMed ID: 9707742
[TBL] [Abstract][Full Text] [Related]
9. Tolerability of 3-day, once-daily azithromycin suspension versus standard treatments for community-acquired paediatric infectious diseases.
Treadway G; Reisman A
Int J Antimicrob Agents; 2001 Nov; 18(5):427-31. PubMed ID: 11711256
[TBL] [Abstract][Full Text] [Related]
10. Cefprozil versus cefaclor in the treatment of mild to moderate skin and skin-structure infections. The Cefprozil Multicenter Study Group.
Parish LC; Doyle CA; Durham SJ; Wilber RB
Clin Ther; 1992; 14(3):458-69. PubMed ID: 1638587
[TBL] [Abstract][Full Text] [Related]
11. Cefpodoxime proxetil suspension compared with cefaclor suspension for treatment of acute otitis media in paediatric patients.
MacLoughlin GJ; Barreto DG; de la Torre C; Pinetta EA; del Castillo F; Palma L
J Antimicrob Chemother; 1996 Mar; 37(3):565-73. PubMed ID: 9182113
[TBL] [Abstract][Full Text] [Related]
12. Randomized, double-blind, multicenter comparison of oral cefditoren 200 or 400 mg BID with either cefuroxime 250 mg BID or cefadroxil 500 mg BID for the treatment of uncomplicated skin and skin-structure infections.
Bucko AD; Hunt BJ; Kidd SL; Hom R
Clin Ther; 2002 Jul; 24(7):1134-47. PubMed ID: 12182257
[TBL] [Abstract][Full Text] [Related]
13. Cefprozil versus cefaclor in the treatment of acute and uncomplicated urinary tract infections. Cefprozil Multicenter Study Group.
Iravani A; Doyle CA; Durham SJ; Wilber RB
Clin Ther; 1992; 14(2):314-26. PubMed ID: 1611652
[TBL] [Abstract][Full Text] [Related]
14. Multinational multicenter controlled trial comparing ceftibuten with cefaclor for the treatment of acute otitis media. Members of the Ceftibuten Otitis Media International Study Group.
Blumer JL; Mclinn SE; Deabate CA; Kafetzis DA; Perrotta RJ; Salgado O
Pediatr Infect Dis J; 1995 Jul; 14(7 Suppl):S115-20. PubMed ID: 7567311
[TBL] [Abstract][Full Text] [Related]
15. Azithromycin versus cefaclor in the treatment of acute bacterial pneumonia.
Kinasewitz G; Wood RG
Eur J Clin Microbiol Infect Dis; 1991 Oct; 10(10):872-7. PubMed ID: 1662636
[TBL] [Abstract][Full Text] [Related]
16. [Clinical evaluation of cefpodoxime proxetil in the treatment of skin and soft tissue infections. A double blind comparison of cefpodoxime proxetil and cefaclor].
Yura J; Shinagawa N; Mizuno A; Watanabe S; Ando M; Sakai K; Ueda T; Morimoto K; Nakamura T; Hashimoto I
Jpn J Antibiot; 1988 Oct; 41(10):1517-37. PubMed ID: 3060626
[TBL] [Abstract][Full Text] [Related]
17. Comparative efficacy of cefadroxil and cefaclor in the treatment of skin and soft-tissue infections.
Ballantyne FN
Clin Ther; 1985; 7(4):487-91. PubMed ID: 4016827
[TBL] [Abstract][Full Text] [Related]
18. Double-blind comparison of cefixime and cefaclor in the treatment of acute otitis media in children.
Piippo T; Stefansson S; Pitkäjärvi T; Lundberg C
Scand J Infect Dis; 1991; 23(4):459-65. PubMed ID: 1957129
[TBL] [Abstract][Full Text] [Related]
19. Comparative studies of cefprozil in the management of skin and soft-tissue infections.
Nolen T
Eur J Clin Microbiol Infect Dis; 1994 Oct; 13(10):866-71. PubMed ID: 7889961
[TBL] [Abstract][Full Text] [Related]
20. Loracarbef (LY163892) versus cefaclor in the treatment of acute bacterial bronchitis.
Dere WH; Farlow D; Therasse DG; Ruoff GE
Clin Ther; 1992; 14(1):41-53. PubMed ID: 1576625
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
